| Literature DB >> 25399943 |
Lindsay Lally1, Lisa R Sammaritano2.
Abstract
The major manifestations of antiphospholipid syndrome (APS) are caused by thrombosis within the venous or arterial vasculature, whereas the vascular lesions in systemic vasculitis result from an inflammatory infiltrate in the vessel wall. There is an association between vascular thrombosis and inflammation, however, as vasculitis can occur in APS and thromboembolic complications are seen in systemic vasculitis. Although differentiating between vasculitis and antiphospholipid-associated thrombosis can be difficult, it may be crucial to do so given the different therapeutic implications for immunosuppression or anticoagulation. This article explores the relationship between thrombosis and inflammation as it relates to APS and systemic vasculitis.Entities:
Keywords: Anti-β2-glycoprotein 1 antibody; Anticardiolipin antibody; Antiphospholipid syndrome; Lupus anticoagulant; Vasculitis
Mesh:
Substances:
Year: 2015 PMID: 25399943 DOI: 10.1016/j.rdc.2014.09.009
Source DB: PubMed Journal: Rheum Dis Clin North Am ISSN: 0889-857X Impact factor: 2.670